GSK — fllwup^ https://fllwup.co/topic/gsk/ Track GSK news in real time — British pharma group centered on vaccines, HIV treatments, and specialty medicines.. fllwup^ collects the latest GSK headlines from every major source into one live feed — free, no account, no algorithm. Sat, 22 Aug 2026 19:29:19 GMT A Look at GSK PLC (GSK) After 3.4% Gain -- GF Value $45.43 vs Prhttps://news.google.com/rss/articles/CBMipAFBVV95cUxOMmpYZjB5eWFTQk1TaG9UTi1kRGU3VjlPQ0lSdzRhLVBtYzM4QzFkejBuZ21QeVEyTDVpQzRKYmJJNUNaTEEza3B1dmhJYkV0ZGs3TEQybXhCUlc5dVZkcFZZUG9XNXJiSkR2N0U2dGZMaFd2N2dxWWxMcFpGRHZpTUFpUXdQa0lSX05VdXNLa0dlNEw0TWNsVGdUQXdpYlZCUmJHSg?oc=5GuruFocus GSK secures preclinical dengue antibody from Chugaihttps://news.google.com/rss/articles/CBMingFBVV95cUxNR01JcE1ETzB3dkpXSDlKdlE0amVVWFhEOTFETnBOQW5kbnM2Z0ZEQ0prUzR3Q2NsNDU5eG1xbHVQUldDR0JqaF85b0YxbFBsQzdJUUQ4U2dwUWdYQTI4TlFQVEhqTDNLRkJUTzlobHM1cWoyLUJPSkdXY1RjR1hVd2dyX0czLWN5eFAzbF90WDFNS0p3cmI0dUxjZmpOQQ?oc=5AllSci GSK (LON:GSK) Earns Hold Rating from Deutsche Bank Aktiengesellschafthttps://news.google.com/rss/articles/CBMivAFBVV95cUxOY0JFRGdiYnFZZHVFcDhPUFlObDR6TGh1SmliZFFFMnNHLVlSNVhfRlI1aDd3TVdQUnNlQVhWNUhwWEdqQUYza1lXQ1Z5UEl0QmRKWjZvTHhpaG5palowZUlnRTNRQ3EzdWh0elczdXJPVW8wS0xQVmJ3cFBKWFNMZjlHbFg0VzBJamZjVHAwTzRlTFN1SjRGRVBZTGJtal9VbzEtdVlUVGJJNjlxRkVydHpORm00bGs0S0RrZw?oc=5MarketBeat GSK Set up for Steady Long-Term Growth As Portfolio and Pipeline Develophttps://news.google.com/rss/articles/CBMiwgFBVV95cUxNd2ViN2lIU2RqMHZDUWt5THNkNkFuWFRKSjVpVHFKUmFDTUhIYXBzRW1KWTF3WGdwc2YyOWpJb3hKamc1NVZONm1tWmRKcGRXbGU1ZndFY2dpbEx4djdYNVZKZm5ZN2FKTWhaOGxyM3p4ck80bGE5WTlOX0NELWFVX3V6bnN0TUo1VXF1RnB2ZG1sVnFuVTRjU0EtN2Y3YjZSejZRanBTeGlndkEzYnJ3T1FvVF82UVExRTdBNGZMd0hlUQ?oc=5Morningstar GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Controlhttps://news.google.com/rss/articles/CBMingFBVV95cUxNSVNTWVlfTUhBcVl0Ui1KVmNEY3hKNE1ULWl2bnpwTWtKNFo5V0Z3SS1VREVLN0xxZUh4VFRGT0VWOVZDeXc0MmhORm5lX1R5VW5oakI2ZGJyZURvN0JJV1hpRE5xN0RCNjJpYll2LXY4Z2NJV0UyQmNrLTdXMmFSNGtUVGI3UHRTNHB6dFRIcDN3b2lKNlRsTElmTEE5dw?oc=5Yahoo Finance GSK lays out plans to cut costs, pursue more late-stage drug trialshttps://news.google.com/rss/articles/CBMipgFBVV95cUxNLTFOS0ZMVEdZM2hxUFpkeTlSbG5PSVA3U3N4VVQ3YUFlWHZiOGFQXy15blBMSUlDX21Xc0dxTXVxT3F0THFTNjdSdnZFMjdGMXNxYXlXYjdIbDAwQzBPdWZ1OS1wNjd3RHRZd2tPYlctOG03WWZRR1hjaU5qS21zZ3l2Znl4UXFvb0o3RjlfNHpvWWtmWlU0OXhnMWZxdVhIbFJYdDBR?oc=5STAT GSK takes full rights to Chugai's experimental anti-dengue virus antibodyhttps://news.google.com/rss/articles/CBMiU0FVX3lxTFBiZzlHQUYtNDNtVVk4NHNvX1prd3EzcWFFbXlicXFrV21BNkxLSnRibnNEVDJnNmFBNHBPSUtPU19VUVJiY1NTeGczb056YnVaRkdN?oc=5FirstWord Pharma M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351https://news.google.com/rss/articles/CBMivAFBVV95cUxOSmk2ODJyekRsRkhXS3pjYjhERF9oaGdsdkxCWVJmeXZNYkxnVzVXMmx1NDhPd0FoeHFCUEk1WUhvekYxZDMtVXBrcGxLR0RTdEdKSUFYSlFhb0k4QUpVUmtkVFdFSm5uYW5UUF9vOFp1WHhubmdQUGlwN040RURfUEdRUnRZR2N5czFiYkhxU3RFY0xiTFFwRENFOHlLYm1uLWd2R1dMNDdwaGdnNU44Yk5EOE8zQ2NwQXBmMw?oc=5Pharmaceutical Executive GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UKhttps://news.google.com/rss/articles/CBMivgFBVV95cUxNNkFJTzB3MmVlX216b3lNcU1aclcyX3pYOW42MGlxejNYei1PdElpUzdWWVNxWXVTM2RzenR3U1Z6VnlkSTZKemFia1EyNWJhU2lhU3FId3JZeFdLZU5BRnpuQUIxZmI5Vm42V0ZBQzkzS1V4eTllbEFFNFdjZWVjQ01hcWVadk1nY1ZfaWdGNG4xWGFNUXRIYnZ3QXk4aXBBcURvN0dNem54SnZMZUFxbEY3MjdSQUFvRGdMdzVR?oc=5GSK GSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugshttps://news.google.com/rss/articles/CBMi4AFBVV95cUxPVEczNGtwNjlyMERkWXlkcVRKckpWU1pBa25VTHQyN0hNS2lYTHBoSHktMXRJMlU3VWU4QTNNanJ5b09jb0dWOXhYeFdkNlNBVEFxY1ZJNFRVMVFGZDlNVldjV3draUFOc1R2X2Qwdm50dHVRd3FIX3p2OWZhUk82aUNoTGlBSTY2MHJtSzV2TERMZG1EaUVuRHlaVERaaFNQOXpUVTZMdDFYTDRUaXAxY1RULXh1QmJxZ255MHZ5b2Q2OGd4TG0yZy1RZkZYUEY4UnprT0M1YWV6eWxLNWU3Vg?oc=5Reuters